Back to Search
Start Over
Triple-negative breast cancer: current perspective on the evolving therapeutic landscape
- Source :
- International Journal of Women's Health. 11:431-437
- Publication Year :
- 2019
- Publisher :
- Informa UK Limited, 2019.
-
Abstract
- Triple-negative breast cancer (TNBC) is known to have a poor prognosis and limited treatment options, namely chemotherapy. Different molecular studies have recently classified TNBC into different subtypes opening the door to potential new-targeted treatment options. In this review, we discuss the current standard of care in the treatment of TNBC in the neoadjuvant, adjuvant and metastatic settings. In addition, we summarize the ongoing phase III clinical trials evaluating different associations between the 3 pillars of anticancer treatment: chemotherapy, targeted therapy and immunotherapy.
- Subjects :
- Oncology
medicine.medical_specialty
Chemotherapy
Poor prognosis
business.industry
medicine.medical_treatment
Obstetrics and Gynecology
Phases of clinical research
Immunotherapy
medicine.disease
Targeted therapy
Breast cancer
Internal medicine
Maternity and Midwifery
Medicine
business
Adjuvant
Triple-negative breast cancer
Subjects
Details
- ISSN :
- 11791411
- Volume :
- 11
- Database :
- OpenAIRE
- Journal :
- International Journal of Women's Health
- Accession number :
- edsair.doi...........2b3fe351676a944bb6fd8a11bca44782